3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
3
Leukemia, Hairy Cell
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oropharyngeal Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
35
fludarabine
18
Methotrexate
17
fludarabine phosphate
16
Dexamethasone
16
blinatumomab
15
Vincristine
15
Cytarabine
14
Melphalan
12
Tacrolimus
11
Etoposide
11
pegaspargase
10
Whole-Body Irradiation
9
Mercaptopurine
9
Calcium Dobesilate
9
merphos
8
Dasatinib
8
Busulfan
8
Asparaginase
8
Thiotepa
7
Prednisone
7
Mycophenolic Acid
7
Leucovorin
7
Granulocyte Colony-Stimulating Factor
7
Doxorubicin
7
prednylidene
6
ponatinib
6
calaspargase pegol
6
Stem Cell Transplantation
6
Specimen Handling
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Diphenhydramine
×
Clear all
NCT00840853
2025-07-09
MULTIPRAT
Baylor College of Medicine
Phase 1
Active not recruiting
68 enrolled